http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23757193

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Review
endingPage 333
issn 1093-4715
1093-9946
issueIdentifier 2
pageRange 313-333
publicationName Frontiers in bioscience (Landmark edition)
startingPage 313
bibliographicCitation Moghadas M, Essa MM, Ba-Omar T, Al-Shehi A, Qoronfleh MW, Eltayeb EA, Guillemin GJ, Manivasagam T, Justin-Thenmozhi A, Al-Bulushi BS, Al-Adawi S, Edalatmanesh MA. Antioxidant therapies in attention deficit hyperactivity disorder. Front Biosci (Landmark Ed). 2019 Jan 01;24(2):313–33. doi: 10.2741/4720. PMID: 30468658.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbff54f1e811eefa389685fd81f62d3b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8f09ae7212531a547fadc8cd076ca89
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c7cd0f0d92d79aec268fcf00a041988
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0218f12738437fe8fd9372f5abad973a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5dc4e705210a9ce922c0bc8ac150742f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c92d18d367a13155b52d819e03984ef4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23d3b65d34998cf5cc3ae2b8095978a9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8bb0f2b4cbe4b08ac0e4ecac2ebd16f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee7c6315be277b0a19ce000e2632bc3e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_365a3d9f4190d7a08bf84dbc50a93572
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfcc1a24552593bda6e4767007a5cb3b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_346eb4dfdf25725d3fa1ecad14629438
date 2019-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.2741/4720
https://pubmed.ncbi.nlm.nih.gov/30468658
isPartOf https://portal.issn.org/resource/ISSN/1093-9946
https://portal.issn.org/resource/ISSN/1093-4715
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/29838
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Antioxidant therapies in attention deficit hyperactivity disorder
discusses http://id.nlm.nih.gov/mesh/M0557421
http://id.nlm.nih.gov/mesh/M0009388
http://id.nlm.nih.gov/mesh/M0001797
http://id.nlm.nih.gov/mesh/M0001491
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001289Q000188
http://id.nlm.nih.gov/mesh/D000975Q000627
http://id.nlm.nih.gov/mesh/D018384Q000502
http://id.nlm.nih.gov/mesh/D001688Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D001205Q000627
http://id.nlm.nih.gov/mesh/D001289Q000503
http://id.nlm.nih.gov/mesh/D002648
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D012307
http://id.nlm.nih.gov/mesh/D005978Q000627
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11494
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7000
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6997
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8077

Total number of triples: 50.